Paclitaxel-Coated PTA Balloon Catheter
The Ranger Drug Coated balloon is indicated for Percutaneous Transluminal Angioplasty (PTA) in the peripheral vasculature. It has been designed to provide consistent and predictable drug delivery through efficient drug transfer, and a strong coating integrity.
Ranger™, for consistent and predictable drug delivery
We developed TransPax™, a proprietary coating technology designed to optimize the drug coating integrity and efficiently deliver the drug to the tissue. A loading tool and Sterling™ balloon also contribute to coating integrity, deliverability and intuitive use. With these innovations the Ranger™ DCB provides a consistent and predictable treatment option.
During the PTA procedure, the coating on drug coated balloons can be damaged prior to lesion treatment. This may result in the drug and excipient flaking off the balloon before reaching the lesion. As a consequence, the actual drug delivery to the lesion may be non-homogeneous and inconsistent.
The Next Generation of Drug-Coated Balloon: Ranger™ Paclitaxel-Coated PTA Balloon Catheter
Proprietary TransPax coating is designed for optimal drug transfer minimizing risk for particulate loss downstream
A broad size matrix with BTK and SFA indications
Jul 11, 2017
PDF, 1004.0 KB
Jul 19, 2017
Ranger SFA 12 month data sheet
PDF, 2.0 MB